GLOBAL CELL AND TISSUE PRESERVATION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Cell and Tissue Preservation Market, By Type (Cell (Mammalian Cells, Others (Microorganisms and Plant Cells)), Tissue (Blood, Bone, Soft Tissues, Skin)), By Product (Equipments (Kits & Reagents, Freezers & Refrigerators, Storage Systems, Others), Software, Bio-preservation Media, Home-brew Media , Pre-formulated Media), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development), By End User (Biobanks & Cell banks, Hospitals & Diagnostics Labs, Research Laboratories, Others), By Preservation Technique (Cryopreservation, Ambient Temperature Storage, Temperature-controlled Storage, Drying / Freeze-Drying, Radiation , Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Jul 2024
Code : CMI7204
Pages :160
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global Cell and Tissue Preservation Market Regional insights

To learn more about this report, Request sample copy

North America dominates the global cell and tissue preservation market with an estimated market share of 40.2% in 2024, owing to strong healthcare infrastructure and high adoption of advanced technologies in the region. The presence of leading life sciences research companies and large biopharma players has ensured perpetual innovations and demand for cell and tissue preservation solutions. Furthermore, significant funding from both public and private sectors for medical research activities involving cell therapies, regenerative medicines and tissue engineering can drive the market growth. With major markets like the U.S. and Canada hosting top medical schools and research institutes, North America remains the hub for trailblazing researches using preserved biomaterials.

Asia Pacific has emerged as the fastest growing regional market for cell and tissue preservation in recent years. Rapid economic expansion, growing healthcare expenditure and rising patient awareness in Asia Pacific can drive the market growth. China, Japan and India have demonstrated strong focus on developing their healthcare infrastructure as well as life sciences industry. This has lured many international preservation solution providers to set up manufacturing units and research facilities in Asia to capture the business opportunities. Governments across Asia are introducing favorable regulations and incentives to encourage local bioscience startups and boost medical tourism. As a result, Asian countries are fast emerging as strategic sourcing destinations for various preserved biomaterials.